ZD55-IL-24 eradicates established melanoma in A375-bearing immunocompromised mouse model mainly through the direct pathway of inducing tumor-selective cytotoxicity, but not through the indirect pathway of inducing antitumor immunity and inhibiting angiogenesis. Here, IL24 is linked to neoplasm.